TYMS and diffuse large B-cell lymphoma: The failure of thymidylate synthase inhibitors 5-fluorouracil and methotrexate to induce MHC-I in our screen (Fig 2F) may be attributable to cell line differences (PDAC vs DLBCL), dose/duration considerations, or the use of different thymidylate synthase inhibitors than in their study (which used pemetrexed and raltitrexed).